Audrey Delmas

DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness

C. Etiévant, G. Favre, D. Hoon, 2022, bioRxiv.

Demethylation by low-dose 5-aza-2′-deoxycytidine impairs 3D melanoma invasion partially through miR-199a-3p expression revealing the role of this miR in melanoma

C. Etiévant, G. Favre, J. Tost, 2019, Clinical Epigenetics.

The c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors

G. Favre, O. Sordet, N. Meyer, 2015, Oncotarget.

Integrated Pharmacokinetic/Pharmacodynamic Model of a Bispecific CD3xCD123 DART Molecule in Nonhuman Primates: Evaluation of Activity and Impact of Immunogenicity

D. Mager, M. Chenel, G. Chichili, 2018, Clinical Cancer Research.

Establishment and mitotic characterization of new Drosophila acentriolar cell lines from DSas-4 mutant

H. Maiato, A. Guichet, A. Debec, 2013, Biology Open.

Exploring preferences of different modes of administration of hypomethylating agent treatments among patients with acute myeloid leukemia

L. Batchelder, Audrey Delmas, D. Bruhn, 2023, Frontiers in Oncology.

First-in-human phase I study of oral S49076, a unique MET/AXL/FGFR inhibitor, in advanced solid tumours.

P. Nuciforo, J. Soria, A. Hollebecque, 2017, European journal of cancer.